Browse evidence-based analysis of health-related claims and assertions
Log in to see full claim details, scientific mechanisms, and cited studies.
People aged 66 and older who develop shingles have a nearly 90% higher chance of having a stroke in the first two weeks after the infection, with the risk gradually decreasing over the next six...
The recombinant zoster vaccine is linked to lower shingles risk in adults with various chronic skin conditions — including psoriasis, eczema, hidradenitis, vitiligo, and pemphigoid — indicating it...
In adults with chronic skin conditions like psoriasis or eczema, the recombinant zoster vaccine is linked to a lower chance of developing severe shingles that leads to hospitalization or widespread...
In adults with chronic skin conditions like psoriasis or eczema, the recombinant zoster vaccine is linked to a lower chance of developing shingles that affects the eye, which can lead to vision loss,...
In adults with chronic skin conditions like psoriasis or eczema, two doses of the recombinant zoster vaccine are linked to a 39% lower chance of developing long-lasting nerve pain after shingles,...
In adults with chronic skin conditions like psoriasis or eczema, two doses of the recombinant zoster vaccine are linked to a 39% lower chance of developing shingles compared to the older live...
Adults aged 50 and older who received any form of shingles vaccine had a lower rate of dementia diagnosis over three and five years compared to those who received the pneumococcal vaccine, though...
Adults aged 50 and older who received the recombinant shingles vaccine had a lower rate of dementia diagnosis over three and five years compared to those who received the older live shingles vaccine,...
Adults aged 50 and older who received the recombinant shingles vaccine had a lower rate of dementia diagnosis over three and five years compared to those who received the pneumococcal vaccine, though...
In mice, the AS01 adjuvant triggers immune responses that reduce brain plaques linked to Alzheimer’s, and researchers suspect a similar process might occur in humans—but this has not been proven yet.
Because two different vaccines with the same adjuvant (AS01) both showed similar reductions in dementia risk, the protective effect is likely due to the adjuvant itself, not the specific virus each...
Older adults who received both the AS01-adjuvanted shingles and RSV vaccines had a greater reduction in dementia diagnosis risk than those who received only one, but not enough greater to suggest the...
Older adults who received the AS01-adjuvanted RSV vaccine were less likely to be diagnosed with dementia within 18 months than those who received the flu vaccine, with an average of 87 additional...
Older adults who received the AS01-adjuvanted shingles vaccine were less likely to be diagnosed with dementia within 18 months compared to those who received the flu vaccine, with an average of 53...
For adults with type 1 diabetes, receiving the shingles vaccine is linked to a 75% lower risk of heart attack or stroke, a finding that has never been shown before in research.
The shingles vaccine appears to offer the greatest protection against heart attacks and strokes in the first year after vaccination, with benefits fading over time and disappearing entirely after 10...
Adults with diabetes who receive the shingles vaccine are nearly half as likely to die from any cause over several years compared to those who don’t, even after accounting for age and other health...
Adults with diabetes who receive the shingles vaccine have a 21% lower risk of stroke over time compared to those who don’t, regardless of whether they have type 1 or type 2 diabetes.
Adults with diabetes who get the shingles vaccine have a 27% lower risk of developing coronary artery disease over time compared to those who don’t, regardless of whether they have type 1 or type 2...
Adults with diabetes who receive the shingles vaccine have a 24% lower risk of having a heart attack or stroke over several years compared to those who do not, even after accounting for age, sex, and...
Among people aged 70 to 79, receiving the shingles vaccine does not lead to more doctor visits overall in the six weeks after vaccination, as the number of visits remained nearly the same as during...
Among people aged 70 to 79, the shingles vaccine does not lead to a higher rate of rashes or rashes requiring antiviral treatment in the six weeks after vaccination, as the rates were similar to what...
Among people aged 70 to 79, there is no evidence that the shingles vaccine increases the risk of heart attacks in the six weeks after vaccination, as the rate of heart attacks was similar to what is...
Among people aged 70 to 79, there is a statistically lower rate of stroke diagnoses in the six weeks after receiving the shingles vaccine compared to other times, but this is likely due to...